Vonjo is a medicine called a kinase inhibitor that is used to treat certain types of a blood disorder called myelofibrosis. Myelofibrosis is a type of blood cancer that causes scarring (fibrosis) in ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--Onco360 ®, the nation’s leading independent Specialty Pharmacy, has been selected by CTI BioPharma to be a specialty pharmacy partner for VONJO (pacritinib), which is ...
More than half of patients with myelofibrosis and low platelets treated with Vonjo saw platelets rise 58% and hemoglobin levels improve. More than half of patients with low platelets (thrombocytopenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback